Feagan BG, Danese S, Loftus EV Jr, Vermeire S, et al. Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial. Lancet 2021 Jun 3. pii: S0140-6736(21)00666.
PMID: 34090625